LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00033333
 19.69 84.90 33 1239 0.0266 -0.2168
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 19.69 84.90 1263 1239 1.0190 1.0098
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 19.69 84.90 38 1239 0.0307 -0.1877
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 19.69 84.90 1265 1239 1.0206 1.0106
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 21.40 84.90 52 1454 0.0357 -0.1127
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 21.40 84.90 1353 1454 0.9301 0.9650
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 21.40 84.90 42 1454 0.0289 -0.1578
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 21.40 84.90 1414 1454 0.9720 0.9862
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 23.10 84.90 63 1616 0.0390 -0.0678
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 23.10 84.90 1437 1616 0.8891 0.9455
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 23.10 84.90 70 1616 0.0433 -0.0444
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 23.10 84.90 1585 1616 0.9807 0.9909
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 24.81 84.90 77 1769 0.0435 -0.0220
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 24.81 84.90 1564 1769 0.8839 0.9444
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 24.81 84.90 72 1769 0.0407 -0.0369
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 24.81 84.90 1692 1769 0.9562 0.9797
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 26.51 84.90 103 1923 0.0536 0.0439
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 26.51 84.90 1596 1923 0.8299 0.9189
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 26.51 84.90 86 1923 0.0447 0.0029
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 26.51 84.90 1733 1923 0.9011 0.9543
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 28.21 84.90 106 2091 0.0507 0.0492
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 28.21 84.90 1713 2091 0.8190 0.9155
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 28.21 84.90 99 2091 0.0473 0.0338
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 28.21 84.90 1904 2091 0.9103 0.9598
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 29.92 84.90 121 2237 0.0541 0.0780
MN20160318_Q02
E16